Evaluation of streptonigrin (NSC-45383) by continuous intravenous infusion in the treatment of advanced gastrointestinal cancer.
D000230:Adenocarcinoma / Q000188:drug therapy; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D013308:Streptonigrin / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D013308:Streptonigrin